BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 17700557)

  • 1. Should all patients with systemic lupus erythematosus receive cardioprotection with statins?
    Toloza S; Urowitz MB; Gladman DD
    Nat Clin Pract Rheumatol; 2007 Oct; 3(10):536-7. PubMed ID: 17700557
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumor necrosis factor-alpha as a potential target in the treatment of systemic lupus erythematosus: a role for the HMG-CoA reductase inhibitor simvastatin.
    Kotyla PJ; Sliwinska-Kotyla B; Kucharz EJ
    J Rheumatol; 2006 Nov; 33(11):2361-3; author reply 2363. PubMed ID: 17086617
    [No Abstract]   [Full Text] [Related]  

  • 3. Premature atherosclerosis-related central nervous system involvement in two cases of systemic lupus erythematosus.
    Zhang X; Tian X; Zhang F
    J Clin Rheumatol; 2007 Aug; 13(4):211-2. PubMed ID: 17762456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Causal mechanism for atherosclerosis or coronary heart disease in women: a constellation of components.
    Agrinier N; Cournot M; Ruidavets JB; Ahluwalia N; Ferrières J
    Maturitas; 2010 Apr; 65(4):404-5. PubMed ID: 20181447
    [No Abstract]   [Full Text] [Related]  

  • 5. Dual effects of statins therapy in systemic lupus erythematosus and SLE-related atherosclerosis: the potential role for regulatory T cells.
    Tu H; Li Q; Xiang S; Jiang H; Mao Y; Shou Z; Chen J
    Atherosclerosis; 2012 May; 222(1):29-33. PubMed ID: 22417842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic lupus erythematosus and accelerated atherosclerosis.
    Hahn BH
    N Engl J Med; 2003 Dec; 349(25):2379-80. PubMed ID: 14681501
    [No Abstract]   [Full Text] [Related]  

  • 7. Intensive cholesterol lowering: no longer a myth.
    Bitzur R; Harats D
    Isr Med Assoc J; 2005 Dec; 7(12):816-7. PubMed ID: 16382708
    [No Abstract]   [Full Text] [Related]  

  • 8. Accelerated atherosclerosis in systemic lupus erythematosus: perspectives towards decreasing cardiovascular morbidity and mortality.
    Escárcega RO; Garcia-Carrasco M; Jara LJ; Cervera R
    Lupus; 2009 Apr; 18(5):383-6. PubMed ID: 19318388
    [No Abstract]   [Full Text] [Related]  

  • 9. Viewpoint: Terje R. Pedersen, MD, PhD. Interview by Robert Short.
    Pedersen TR
    Circulation; 2007 Mar; 115(12):f51-2. PubMed ID: 17393574
    [No Abstract]   [Full Text] [Related]  

  • 10. Statins. Cholesterol lowering and beyond.
    Mayo Clin Womens Healthsource; 2006 Jun; 10(6):1-2. PubMed ID: 16675916
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapeutic potential of nitric oxide donors in the prevention and treatment of atherosclerosis.
    Herman AG; Moncada S
    Eur Heart J; 2005 Oct; 26(19):1945-55. PubMed ID: 15911567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antiinflammatory effects of statins.
    McCullough PA
    N Engl J Med; 2001 Oct; 345(16):1209; author reply 1210-1. PubMed ID: 11642241
    [No Abstract]   [Full Text] [Related]  

  • 13. Statins, low cholesterol, and hemorrhagic stroke: an uncertain triangle.
    Jacobs BS; Greenberg SM
    Neurology; 2008 Jun; 70(24 Pt 2):2355-6. PubMed ID: 18541869
    [No Abstract]   [Full Text] [Related]  

  • 14. Summary of the role of statins in the treatment of dyslipidemia.
    Carr LL
    J Am Osteopath Assoc; 2003 Jul; 103(7 Suppl 3):S1-3. PubMed ID: 12884937
    [No Abstract]   [Full Text] [Related]  

  • 15. Achieving cholesterol goals. Current and future drug therapies.
    Jones PH
    Postgrad Med; 2003 Aug; 114(2 Suppl):14-21. PubMed ID: 19667635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pleiotropic effect of statins in haemodialysis patients is not the consequence of an inhibition of LDL oxidation by myeloperoxidase.
    Van Antwerpen P; Boudjeltia KZ; Vaes M; Babar S; Madhoun P; Moguilevsky N; Vanhaeverbeek M; Néve J; Ducobu J
    Nephrol Dial Transplant; 2006 Sep; 21(9):2672-4. PubMed ID: 16574674
    [No Abstract]   [Full Text] [Related]  

  • 17. Risk associated with statin treatment.
    Kjekshus J
    J Am Coll Cardiol; 2008 Jan; 51(1):91; author reply 92. PubMed ID: 18174047
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardiovascular disease in lupus patients: should all patients be treated with statins and aspirin?
    Bruce IN
    Best Pract Res Clin Rheumatol; 2005 Oct; 19(5):823-38. PubMed ID: 16150405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of statins in the prevention of atherosclerosis in patients with systemic lupus erythematosus--a meta-analysis of randomized controlled trials.
    Ye Y; Zhao X; Xie H; Tian Z; Zhang S
    Int J Cardiol; 2013 Jul; 167(1):301-3. PubMed ID: 23084817
    [No Abstract]   [Full Text] [Related]  

  • 20. New evidence supporting aggressive lipid lowering.
    Stein EA
    Postgrad Med; 2003 Apr; 113(4 Suppl):31-40. PubMed ID: 19667621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.